BIOLOGICAL AGENTS IN THE TREATMENT OF MODERATE TO SEVERE PSORIASIS: A PHARMACOECONOMIC ANALYSIS

被引:0
|
作者
Riveros, B. S. [1 ]
Souza, T. T. [1 ]
Godoy, R. R. [1 ]
Garcia, M. [1 ]
Goncalves, P. [1 ]
Rotta, I [1 ]
Otuki, M. F. [1 ]
Pontarolo, R. [1 ]
Correr, C. J. [1 ]
机构
[1] Univ Fed Parana, BR-80060000 Curitiba, Parana, Brazil
关键词
D O I
10.1016/j.jval.2013.08.2276
中图分类号
F [经济];
学科分类号
02 ;
摘要
引用
收藏
页码:A726 / A726
页数:1
相关论文
共 50 条
  • [31] What are the objectives of moderate to severe psoriasis treatment?
    Ortonne, J. -P.
    [J]. ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2008, 135 : S281 - S284
  • [32] Tofacitinib for the treatment of moderate-to-severe psoriasis
    Chiricozzi, Andrea
    Faleri, Sara
    Saraceno, Rosita
    Bianchi, Luca
    Buonomo, Oreste
    Chimenti, Sergio
    Chimenti, Maria Sole
    [J]. EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2015, 11 (04) : 443 - 455
  • [33] Treatment changes in patients with moderate to severe psoriasis
    Anderson, Kathryn
    Feldman, Steven
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB256 - AB256
  • [34] Update on risankizumab for the treatment of moderate to severe psoriasis
    Al-Janabi, A.
    Warren, R. B.
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2020, 20 (11) : 1245 - 1251
  • [35] Efalizumab for the treatment of moderate to severe plaque psoriasis
    Jordan, JK
    [J]. ANNALS OF PHARMACOTHERAPY, 2005, 39 (09) : 1476 - 1482
  • [36] The use of methotrexate in treatment of moderate to severe psoriasis
    Leung, W. Y.
    Lau, K. H.
    [J]. HONG KONG JOURNAL OF DERMATOLOGY & VENEREOLOGY, 2009, 17 (01): : 13 - 19
  • [37] Risankizumab for the Treatment of Moderate to Severe Plaque Psoriasis
    Li, Wendy
    Ghamrawi, Rima
    Haidari, Wasim
    Feldman, Steven R.
    [J]. ANNALS OF PHARMACOTHERAPY, 2020, 54 (04) : 380 - 387
  • [38] Treatment of moderate-to-severe plaque psoriasis
    Salgo, R.
    Thaci, D.
    [J]. GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2009, 144 (06): : 701 - 711
  • [39] Assessment of biological agents in the treatment regimen of moderate to severe Crohn's disease
    Chau, Ngoc-Anh
    Romero, Deandra
    Toolsie, Priya
    Jimmy, Jiny
    Bleidt, Barry A.
    [J]. PHARMACOTHERAPY, 2015, 35 (11): : E299 - E300
  • [40] Pharmacoeconomic model of topical treatment options of mild to moderate psoriasis vulgaris in Germany
    Augustin, Matthias
    Radtke, Marc
    van Engen, Anke
    Ruedig, Cornelia
    Lapp, Christina
    Moehling, Ulrich
    [J]. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2009, 7 (04): : 329 - 338